Hepatitis C Virus Infection Completed Phase 1 / 2 Trials for Ombitasvir (DB09296)

Indication	Status	Phase
DBCOND0033268 (Hepatitis C Virus Infection)	Completed	1 / 2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04378608	Ombitasvir /Paritaprevir/Ritonavir Plus Ribavirin on HCV GT4	Treatment	Ombitasvir (DB09296) Pancrelipase protease (DB11066) Paritaprevir (DB09297) Ribavirin (DB00811) Serine (DB00133)